Evidence map›Paper›PMID 31840538›Full record

SynthesisThe Journal of international medical research2024

Zhang Lin, Shi Hong Wang, Da Yong Wei, Lu Min Wang, Zhong Wu Zhang

Abstract readMeta-Analysis
In one paragraph

Synthesis in The Journal of international medical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Frontiers in cardiovascular medicine · 2020
    Pooled it
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhang LinDepartment of Cardiology, Fujian Provincial Geriatric Hospital, Fujian Provincial Hospital North Branch, Fujian, China.
Shi Hong WangDepartment of Cardiology, Fujian Provincial Geriatric Hospital, Fujian Provincial Hospital North Branch, Fujian, China.
Da Yong WeiDepartment of Cardiology, Fujian Provincial Geriatric Hospital, Fujian Provincial Hospital North Branch, Fujian, China.
Lu Min WangDepartment of Cardiology, Fujian Provincial Geriatric Hospital, Fujian Provincial Hospital North Branch, Fujian, China.
Zhong Wu ZhangDepartment of Cardiology, Fujian Provincial Geriatric Hospital, Fujian Provincial Hospital North Branch, Fujian, China.ORCID 0000-0002-5507-0319

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveCoronary artery disease (CAD) is the leading cause of morbidity and mortality in the world. The proprotein convertase subtilisin/kexin type 9 (

methodsA total of 225 patients and 189 control subjects were recruited in this study. DNA was extracted from peripheral blood samples and was genotyped by mass array method. In addition, we also conducted a meta-analysis of case-control studies to elucidate the relationship of CAD and polymorphism.

resultsThe GG genotype of

conclusionOur results demonstrated that

Indexed as

Coronary Artery DiseaseGenetic Predisposition to DiseasePolymorphism, Single NucleotideProprotein Convertase 9AgedCase-Control StudiesChinaEast Asian PeopleFemaleGenotypeHumansMaleMiddle AgedOdds RatioRisk FactorsPCSK9 protein, humanProprotein Convertase 9CADCoronary artery diseaselow density lipoprotein cholesterolPCSK9polymorphismproprotein convertase subtilisin/kexin type 9

Identifiers

PMID31840538
PMCPMC11465380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.